UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 31

Sortiert nach

MetMAb, the one-armed 5D5 anti-c-Met antibody, inhibits orthotopic pancreatic tumor growth and improves survival

Cancer research (Chicago, Ill.), 2008-06, Vol.68 (11), p.4360-4368

2008

Volltextzugriff (PDF)

Pegylated liposomal doxorubicin: Proof of principle using preclinical animal models and pharmacokinetic studies

Seminars in oncology, 2004-12, Vol.31 (6 Suppl 13), p.16-35

2004

Volltextzugriff (PDF)

Response to protocol review scenario: first do no harm

Lab animal, 2012-10, Vol.41 (10), p.279

Colbern, Gail T

2012

Volltextzugriff (PDF)

STEALTH liposome-encapsulated cisplatin (SPI-77) versus carboplatin as adjuvant therapy for spontaneously arising osteosarcoma (OSA) in the dog: a randomized multicenter clinical trial

Cancer chemotherapy and pharmacology, 2002-08, Vol.50 (2), p.131-136

2002

Volltextzugriff (PDF)

The role of the liposomal anthracyclines and other systemic therapies in the management of advanced breast cancer

Seminars in oncology, 2004-12, Vol.31 (6 Suppl 13), p.106-146

2004

Volltextzugriff (PDF)

Comparative pharmacokinetics, tissue distribution, and therapeutic effectiveness of cisplatin encapsulated in long-circulating, pegylated liposomes (SPI-077) in tumor-bearing mice

Cancer chemotherapy and pharmacology, 1999, Vol.43 (1), p.1-7

1999

Volltextzugriff (PDF)

Dual Promoter–Controlled Oncolytic Adenovirus CG5757 Has Strong Tumor Selectivity and Significant Antitumor Efficacy in Preclinical Models

Clinical cancer research, 2005-12, Vol.11 (24), p.8845-8855

2005

Volltextzugriff (PDF)

Should clinical complications affect USDA pain categories? C is correct

Lab animal, 2007-11, Vol.36 (10), p.14

2007

Volltextzugriff (PDF)

Characterization of a novel, trastuzumab resistant human breast cancer cell line

Frontiers in bioscience (Elite edition), 2010-01, Vol.2 (2), p.627

2010

Volltextzugriff (PDF)

Anti-HER2 immunoliposomes: Enhanced efficacy attributable to targeted delivery

Clinical cancer research, 2002-04, Vol.8 (4), p.1172-1181

2002

Volltextzugriff (PDF)

Breeding without research. Spirit of the 3Rs

Lab animal, 2010-02, Vol.39 (2), p.33

2010

Volltextzugriff (PDF)

Systemic and tumor disposition of platinum after administration of cisplatin or STEALTH liposomal-cisplatin formulations (SPI-077 and SPI-077 B103) in a preclinical tumor model of melanoma

Cancer chemotherapy and pharmacology, 2004-04, Vol.53 (4), p.329-336

2004

Volltextzugriff (PDF)

Encapsulation of the topoisomerase I inhibitor GL147211C in pegylated (STEALTH) liposomes: pharmacokinetics and antitumor activity in HT29 colon tumor xenografts

Clinical cancer research, 1998-12, Vol.4 (12), p.3077-3082

1998

Volltextzugriff (PDF)

Expression of the nonclassic histocompatibility antigen HLA-G by preeclamptic placenta

American journal of obstetrics and gynecology, 1994-05, Vol.170 (5), p.1244-1250

1994

Volltextzugriff (PDF)

Therapy of a xenografted human colonic carcinoma using cisplatin or doxorubicin encapsulated in long‐circulating pegylated stealth liposomes

International journal of cancer, 1999-01, Vol.80 (1), p.134-137

1999

Volltextzugriff (PDF)

311. Oncolytic Adenovirus CG5757 Preferentially Infects Primary Human Tumor Tissues and Shows Strong Anti-Tumor Activity in Tumor Models Following Systemic Administration

Molecular therapy, 2005-05, Vol.11 (S1), p.S121-S121

2005

Volltextzugriff (PDF)

Expression of the nonclassic histocompatibility antigen HLA-G by preeclamptic placenta

American journal of obstetrics and gynecology, 1994-05, Vol.170 (5), p.1244-1250

1994

Volltextzugriff (PDF)

Pegylated liposomal doxorubicin: Proof of principle using preclinical animal models and pharmacokinetic studies: Established and emerging roles of liposomal anthracyclines in oncology

Seminars in oncology, 2004, Vol.31 (6), p.16-35

2004

Volltextzugriff (PDF)

The role of the liposomal anthracyclines and other systemic therapies in the management of advanced breast cancer: Established and emerging roles of liposomal anthracyclines in oncology

Seminars in oncology, 2004, Vol.31 (6), p.106-146

2004

Volltextzugriff (PDF)

Systemic and tumor disposition of platinum after administration of cisplatin or STEALTH liposonlal-cisplatin formulations (SPI-077 and SPI-077 B103) in a preclinical tumor model of melanoma

Cancer chemotherapy and pharmacology, 2004, Vol.53 (4), p.329-336

2004

Volltextzugriff (PDF)

Anti-HER2 Immunoliposomes

Clinical cancer research, 2002-04, Vol.8 (4), p.1172

2002

Volltextzugriff (PDF)

Tumor Uptake and Therapeutic Effects of Drugs Encapsulated in Long-Circulating Pegylated Stealth® Liposomes

Journal of liposome research, 2000, Vol.10 (1), p.81-92

2000

Volltextzugriff (PDF)

Immunology of the maternal-placental interface in normal pregnancy

Seminars in perinatology, 1991-06, Vol.15 (3), p.196-205

1991

Volltextzugriff (PDF)

Targeting of Liposomes to Solid Tumors: The Case of Sterically Stabilized Anti-Her2 Immunoliposomes

Journal of liposome research, 1997-01, Vol.7 (4), p.391-417

1997

Volltextzugriff (PDF)

Pain classification: who is barking up the wrong tree?

Lab animal, 2002-10, Vol.31 (9), p.22

2002

Volltextzugriff (PDF)

1 – 25 von 31

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(30)
Mit Volltextzugriff
(24)

Publikationsform

Artikel
(30)
Buchkapitel
(1)

Sprache

Englisch
(31)
Japanisch
(6)

Erscheinungsjahr

n.n

Thema

Life Sciences & Biomedicine
(18)
Science & Technology
(18)
Animals
(14)
Biological And Medical Sciences
(10)
Humans
(10)
Medical Sciences
(10)
Oncology
(10)
Female
(8)
Mice
(8)
Antineoplastic Agents
(7)
Pharmacology. Drug Treatments
(7)
Liposomes
(6)
Pharmacology & Pharmacy
(6)
Antineoplastic Agents - Administration & Dosage
(5)
Antineoplastic Agents - Therapeutic Use
(5)
Chemotherapy
(5)
Mice, Nude
(5)
Antineoplastic Agents - Pharmacokinetics
(4)
Doxorubicin - Administration & Dosage
(4)
Male
(4)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

MetMAb, the one-armed 5D5 anti-c-Met antibody, inhibits orthotopic pancreatic tumor growth and improves survival

Pegylated liposomal doxorubicin: Proof of principle using preclinical animal models and pharmacokinetic studies

Response to protocol review scenario: first do no harm

STEALTH liposome-encapsulated cisplatin (SPI-77) versus carboplatin as adjuvant therapy for spontaneously arising osteosarcoma (OSA) in the dog: a randomized multicenter clinical trial

The role of the liposomal anthracyclines and other systemic therapies in the management of advanced breast cancer

Comparative pharmacokinetics, tissue distribution, and therapeutic effectiveness of cisplatin encapsulated in long-circulating, pegylated liposomes (SPI-077) in tumor-bearing mice

Dual Promoter–Controlled Oncolytic Adenovirus CG5757 Has Strong Tumor Selectivity and Significant Antitumor Efficacy in Preclinical Models

Should clinical complications affect USDA pain categories? C is correct

Characterization of a novel, trastuzumab resistant human breast cancer cell line

Anti-HER2 immunoliposomes: Enhanced efficacy attributable to targeted delivery

Breeding without research. Spirit of the 3Rs

Systemic and tumor disposition of platinum after administration of cisplatin or STEALTH liposomal-cisplatin formulations (SPI-077 and SPI-077 B103) in a preclinical tumor model of melanoma

Encapsulation of the topoisomerase I inhibitor GL147211C in pegylated (STEALTH) liposomes: pharmacokinetics and antitumor activity in HT29 colon tumor xenografts

Expression of the nonclassic histocompatibility antigen HLA-G by preeclamptic placenta

Therapy of a xenografted human colonic carcinoma using cisplatin or doxorubicin encapsulated in long‐circulating pegylated stealth liposomes

311. Oncolytic Adenovirus CG5757 Preferentially Infects Primary Human Tumor Tissues and Shows Strong Anti-Tumor Activity in Tumor Models Following Systemic Administration

Expression of the nonclassic histocompatibility antigen HLA-G by preeclamptic placenta

Pegylated liposomal doxorubicin: Proof of principle using preclinical animal models and pharmacokinetic studies: Established and emerging roles of liposomal anthracyclines in oncology

The role of the liposomal anthracyclines and other systemic therapies in the management of advanced breast cancer: Established and emerging roles of liposomal anthracyclines in oncology

Systemic and tumor disposition of platinum after administration of cisplatin or STEALTH liposonlal-cisplatin formulations (SPI-077 and SPI-077 B103) in a preclinical tumor model of melanoma

Anti-HER2 Immunoliposomes

Tumor Uptake and Therapeutic Effects of Drugs Encapsulated in Long-Circulating Pegylated Stealth® Liposomes

Immunology of the maternal-placental interface in normal pregnancy

Targeting of Liposomes to Solid Tumors: The Case of Sterically Stabilized Anti-Her2 Immunoliposomes

Pain classification: who is barking up the wrong tree?

Suchergebnisse filtern